Duquesne Family Office's billionaire chief shed a trillion-dollar artificial intelligence (AI) stock in favor of a ...

The head of the FDA's food division, Jim Jones, resigned on Monday following layoffs within the division that he argues were ...

Albert Bourla, Pfizer CEO, joins CNBC's Angelica Peebles and 'Closing Bell Overtime' to talk the impact of tariffs, Pfizer's ...

U.S. President Donald Trump's administration needs to speed up generic drug approvals and exempt some drugs from funding ...

The cuts hit the FDA’s medical device center particularly hard, impacting product reviewers and researchers of AI-enabled ...

Scott Whitaker sent a letter to HHS calling for staff cuts at the FDA to be reversed, arguing patient care and U.S.

Drug company executives on Tuesday touted their industry’s work to keep and make Americans healthy during a Washington event.

Morale is low at the FDA, which was hit with layoffs this week following RFK Jr.’s confirmation. Biopharma leaders and agency ...

The SSA acting commissioner stepped down over requests from DOGE to access data, while the FDA food division head left amid ...

AdvaMed, the medical device lobby, pushed back Wednesday on the Trump administration’s weekend firings of FDA employees.

Loblaw CEO, Per Bank, says company is seeking alternative suppliers to U.S. products that account for ‘less than 10 per cent’ ...

Bausch Health reported strong Q4 results with a 6.2% Y/Y revenue increase and positive net income, driving a 10% stock rally.